Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John Yohan Rhee, M.D.

Concepts (126)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Palliative Care18202436002.540 Why?
Euthanasia22017581.110 Why?
Suicide, Assisted22017681.100 Why?
Postpoliomyelitis Syndrome1202170.770 Why?
Poliomyelitis12021920.710 Why?
Myasthenia Gravis120222140.660 Why?
Myoclonus120191070.630 Why?
Africa520187100.630 Why?
Leukemia, Promyelocytic, Acute120192510.580 Why?
Students, Medical3201719300.500 Why?
Publications120171940.480 Why?
Myocarditis120227870.470 Why?
Research Report120173670.450 Why?
Brain Neoplasms3202390310.440 Why?
Specialization120187790.420 Why?
Health Status Indicators120179700.390 Why?
Quality Indicators, Health Care2201917920.370 Why?
Prediabetic State120165490.350 Why?
Delirium1202116670.340 Why?
Drug Therapy, Combination1201963090.320 Why?
Medicine120179410.320 Why?
Glioblastoma1202334820.290 Why?
Attitude of Health Personnel3201838890.290 Why?
Education, Medical1201817250.260 Why?
Hospice Care220246780.230 Why?
Delivery of Health Care2201953350.220 Why?
Carotid-Cavernous Sinus Fistula12023370.210 Why?
Biomedical Research1201734290.190 Why?
Caregivers2202322370.190 Why?
Diplopia120222140.180 Why?
Interviews as Topic2201826960.170 Why?
Idarubicin12019590.170 Why?
Stroke1202197560.160 Why?
Arsenic Poisoning12019550.160 Why?
Topoisomerase II Inhibitors12019940.160 Why?
Humans3120247614230.160 Why?
Diabetes Mellitus1201658400.140 Why?
Developing Countries3202028850.140 Why?
Delphi Technique220188460.140 Why?
Hospices120202450.140 Why?
Immunity120239970.140 Why?
HIV Infections42016173470.130 Why?
Cameroon12016760.130 Why?
Tretinoin120195190.130 Why?
Antineoplastic Agents12019136370.130 Why?
Capacity Building120182580.120 Why?
Neoplasms12024221640.120 Why?
Geography120176560.120 Why?
Morals120182890.120 Why?
Withholding Treatment120196170.120 Why?
Steroids120199290.110 Why?
Cross-Cultural Comparison120176360.110 Why?
Home Care Services120206480.110 Why?
Remission Induction1201923950.110 Why?
Embolization, Therapeutic1202314180.110 Why?
Qualitative Research1202430230.110 Why?
Internationality1201910010.110 Why?
Directive Counseling120131700.100 Why?
Pharmacies120131690.090 Why?
Condoms120133310.090 Why?
Curriculum1202437410.090 Why?
Risk1202196120.080 Why?
Europe3202134230.080 Why?
Public Health2202126660.080 Why?
Counseling2201315460.080 Why?
Immunotherapy1202346500.070 Why?
Education, Medical, Undergraduate1201610660.070 Why?
Health Education1201310520.070 Why?
T-Lymphocytes12023101940.060 Why?
Quality of Life22023133610.060 Why?
Attitude to Health1201320250.060 Why?
Health Personnel1201833350.060 Why?
World Health Organization2202013160.060 Why?
Physician-Patient Relations1201732490.060 Why?
Intensive Care Units1201737440.060 Why?
Cross-Sectional Studies42024261120.060 Why?
Emergency Service, Hospital2201378740.050 Why?
Sexual Behavior1201321790.050 Why?
Malawi120243040.050 Why?
Healthcare Disparities1201833570.050 Why?
Computer-Assisted Instruction120243620.050 Why?
Mass Screening2201354280.040 Why?
Education, Distance120242600.040 Why?
Patient Acceptance of Health Care1201332040.040 Why?
Vatican City1201810.040 Why?
Consensus2201931220.040 Why?
Prevalence12016157170.040 Why?
Catholicism12018330.040 Why?
HIV-11201668600.040 Why?
Cerebral Angiography1202312810.040 Why?
Female620193925810.030 Why?
Neurology120247800.030 Why?
Spain120174890.030 Why?
Prognosis12016296200.030 Why?
Italy120178430.030 Why?
Urban Population2201320360.030 Why?
Certification120184180.030 Why?
Advisory Committees120187860.030 Why?
Multimedia12013750.030 Why?
Treatment Outcome12019646510.030 Why?
Male520183607360.030 Why?
Cerebral Hemorrhage1202326560.020 Why?
New York120138740.020 Why?
New York City120137310.020 Why?
Pain1202450710.020 Why?
Inpatients1202025480.020 Why?
Referral and Consultation1202136000.020 Why?
Video Recording120139660.020 Why?
Risk-Taking1201310370.020 Why?
CD4 Lymphocyte Count1201325690.020 Why?
Randomized Controlled Trials as Topic12023102030.020 Why?
Aged120191692350.020 Why?
Program Evaluation1201324940.010 Why?
Middle Aged220162208260.010 Why?
Adult220162211480.010 Why?
Social Support1201321720.010 Why?
Patient Education as Topic1201323190.010 Why?
Young Adult32013592070.010 Why?
Child22021801620.010 Why?
Health Services Accessibility1201854410.010 Why?
Adolescent32013883130.010 Why?
Infant, Newborn12020262120.010 Why?
Socioeconomic Factors1201378250.010 Why?
Risk Factors22013741670.010 Why?
Prospective Studies12013544150.000 Why?
Retrospective Studies12013805820.000 Why?
Rhee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (126)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.